Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C23H24N4O3S |
| Molecular Weight | 436.527 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CN(CC1=CC=C(C=C1)S(=O)(=O)N2CCOCC2)C3=C4C=CC=C5C(N)=NC(C=C3)=C45
InChI
InChIKey=CVEGTZWWWRJCFK-UHFFFAOYSA-N
InChI=1S/C23H24N4O3S/c1-26(21-10-9-20-22-18(21)3-2-4-19(22)23(24)25-20)15-16-5-7-17(8-6-16)31(28,29)27-11-13-30-14-12-27/h2-10H,11-15H2,1H3,(H2,24,25)
| Molecular Formula | C23H24N4O3S |
| Molecular Weight | 436.527 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Originator
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Contrasting patterns of DNA fragmentation induced by thymidylate synthase inhibitors, ZD1694 and AG-331. | 1995 |
|
| Product development of AG-331 lyophilized powder for injection. | 1994-01-01 |
|
| Biological activity of a novel rationally designed lipophilic thymidylate synthase inhibitor. | 1994 |
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/8004755
H35 cells treated with 10 microM AG-331 were shown to accumulate in the S phase of the cell cycle. However, when treatments were conducted at a 5-fold higher concentration of AG-331, no S-phase block was apparent, suggesting the loss of a TS-directed effect at high inhibitor concentrations.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 08:48:06 GMT 2025
by
admin
on
Wed Apr 02 08:48:06 GMT 2025
|
| Record UNII |
2027T69J24
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
100000081204
Created by
admin on Wed Apr 02 08:48:06 GMT 2025 , Edited by admin on Wed Apr 02 08:48:06 GMT 2025
|
PRIMARY | |||
|
2027T69J24
Created by
admin on Wed Apr 02 08:48:06 GMT 2025 , Edited by admin on Wed Apr 02 08:48:06 GMT 2025
|
PRIMARY | |||
|
DTXSID90930100
Created by
admin on Wed Apr 02 08:48:06 GMT 2025 , Edited by admin on Wed Apr 02 08:48:06 GMT 2025
|
PRIMARY | |||
|
7493
Created by
admin on Wed Apr 02 08:48:06 GMT 2025 , Edited by admin on Wed Apr 02 08:48:06 GMT 2025
|
PRIMARY | |||
|
CHEMBL9440
Created by
admin on Wed Apr 02 08:48:06 GMT 2025 , Edited by admin on Wed Apr 02 08:48:06 GMT 2025
|
PRIMARY | |||
|
3047716
Created by
admin on Wed Apr 02 08:48:06 GMT 2025 , Edited by admin on Wed Apr 02 08:48:06 GMT 2025
|
PRIMARY | |||
|
C166526
Created by
admin on Wed Apr 02 08:48:06 GMT 2025 , Edited by admin on Wed Apr 02 08:48:06 GMT 2025
|
PRIMARY | |||
|
138384-68-6
Created by
admin on Wed Apr 02 08:48:06 GMT 2025 , Edited by admin on Wed Apr 02 08:48:06 GMT 2025
|
PRIMARY | |||
|
SUB08828MIG
Created by
admin on Wed Apr 02 08:48:06 GMT 2025 , Edited by admin on Wed Apr 02 08:48:06 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT |
|
||
|
|
TARGET -> INHIBITOR |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|